MedTrace Logo

Drug Screening System Method Comparison

NCT06618183 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2024-10-01

No results posted yet for this study

Summary

Prospective, open-label, single-dose, randomized, multi-site performance evaluation of the accuracy and usability Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."

Conditions

  • Reagent Kits, Diagnostic

Interventions

DIAGNOSTIC_TEST

Fingerprint sweat drug screen

Qualitative lateral-flow immunoassay analysis of fingerprint sweat specimen

DIAGNOSTIC_TEST

Fingerprint sweat laboratory analysis

Laboratory analysis of fingerprint sweat specimen by liquid chromatography/tandem mass spectrometry

Sponsors & Collaborators

  • Intelligent Bio Solutions Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-26
Primary Completion
2024-11-30
Completion
2024-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06618183 on ClinicalTrials.gov